Senior insider sale
EVP, Europe Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD — senior position signals high conviction
$7.49M
244.45K shares
What this filing means
DANIELL RICHARD plans to sell 244.45K shares of TEVA PHARMACEUTICAL INDUSTRIES LTD valued at approximately $7.49M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/3/2026ACC: 0001973379-26-000073
Officer· EVP, Europe Commercial
Since Mar 2026
244.45K
Shares to sell
$7.49M
Approx. market value
203.73K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months3
RESTRICTED SHARE UNIT AWARD VESTING EM
COMPENSATION
3/3/2023
24.90KRESTRICTED SHARE UNIT AWARD VESTING EM RETENTION
COMPENSATION
3/3/2023
37.35KPERFORMANCE SHARE UNIT AWARD VESTING
COMPENSATION
3/3/2023
141.48KTotal acquired203.73K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/3/2023 | RESTRICTED SHARE UNIT AWARD VESTING EM COMPENSATION | 24.90K | — |
3/3/2023 | RESTRICTED SHARE UNIT AWARD VESTING EM RETENTION COMPENSATION | 37.35K | — |
3/3/2023 | PERFORMANCE SHARE UNIT AWARD VESTING COMPENSATION | 141.48K | — |
| Total | 203.73K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
115.47K
Market value
$3.31M
12/9/2025
Planned — Approximate Date
NYSEPlanned
Units to sell
128.99K
Market value
$4.17M
3/3/2026
Total
Units
244.45K
Value
$7.49M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/9/2025 | 115.47K | $3.31M | — | Completed |
| Planned — Approximate Date | ||||
3/3/2026 | 128.99K | $4.17M | NYSE | Planned |
| Total | 244.45K | $7.49M | ||